Actavis strikes South Korean distribution deal
This article was originally published in Scrip
Actavisis building up its presence in Asia through a new distribution agreement with the South Korean company J&M Pharma. The exclusive deal covers a number of products and marks the Icelandic generics firm's expansion into what it says is a fast-growing market. Actavis already sells its products in several countries in the Asia-Pacific region including China, Taiwan and Australia.